Combination of Glinides With Premixed Insulin

• Status: Completed
• Trial end date: 2006-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Combination therapy of glinides with premixed insulin provides better glycemic control than premixed insulin alone.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Keio University
• Treatments: Insulin; Insulin, Globin Zinc; Mitiglinide; Nateglinide

Criteria

Inclusion Criteria:

• Clinical diagnosis of type 2 diabetes

• Who undergoes twice daily injection of premixed insulin

• Whose HbA1c is more than 6.5% and less than 8.0%

Exclusion Criteria:

• Whose change of HbA1c is more than 1.0% during 12 weeks observational period